Drawing for CBDINCSAS

USPTO serial 88220128

CBDINCSAS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LOBO, DEBORAH E
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CBDINCSAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Will Hunziker

WILL HUNZIKER HUNZIKER LEGAL SERVICES PLLCC/O WILL HUNZIKER1942 BROADWAY ST SUITE 314BOULDER, CO 80302

Goods and services

ClassDescriptionStatusFirst use
005Anti-epileptic pharmaceutical preparations; Balms for medical purposes; Bath salts for medical purposes; Cardiovascular pharmaceuticals; Dietary supplements for pain relief, inflammation, antipsychotic, anxiety, seizures and neurological disorders, diabetes, cardiovascular health, mood enhancement, sleep aid; Dietary and nutritional supplements; Digestives for pharmaceutical purposes; Medicinal herbs; Medicinal oils; Nutritionally fortified beverages for medical purposes; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for pain relief, inflammation, anti-psychotic, anxiety, seizures and neurological disorders, diabetes, cardiovascular health, mood enhancement, sleep aidACTIVE—
042Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Providing information in the field of plant genetics research resources; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing scientific research information in the field of genetics; Scientific research consulting in the field of genetics; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of geneticsACTIVE—
044Horticultural services; Horticulture consulting services for marketing; Horticulture consulting services for management; Horticulture consulting services for real estates sales; Horticulture consulting services for real estate aquisitionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 4, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 4, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2019DOCKASSIGNED TO EXAMINER—
Jan 6, 2019DOCKASSIGNED TO EXAMINER—
Dec 29, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance